$26.850
+0.615 (+2.29%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Apnimed Inc Stock?
Apnimed, Inc. is a good buy right now due to its strong recent performance, with a year-to-date change of +85.69% and a positive analyst outlook, including a target price of $60 from Cantor Fitzgerald. The upcoming FDA decision for its lead product, Oxnimbi, on February 28, 2027, adds a significant potential catalyst for growth. However, the main risk is the regulatory scrutiny associated with the FDA approval process, which could impact the stock negatively.
APMD stock price ended at $26.85 on Tuesday, after rising +2.29%
Apnimed Inc (APMD) last closed at $26.85, gaining +2.29%. These facts feed the 1-day and 1-week APMD price prediction above.
Forecast Drivers
Apnimed Inc (APMD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
Seasonality analysis for APMD
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.